{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:13:26Z","timestamp":1761513206056},"reference-count":22,"publisher":"The Endocrine Society","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,11,1]]},"abstract":"<jats:sec>\n                  <jats:title>Objective:<\/jats:title>\n                  <jats:p>Effects of GH replacement in patients with GH deficiency (GHD) after a cure for acromegaly so far have been poorly studied, although its prevalence among acromegalic patients may reach the 60%. The aim of the study was to evaluate whether metabolic parameters and quality of life are improved by GH replacement in patients with prior acromegaly and severe GHD.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Design and Methods:<\/jats:title>\n                  <jats:p>This was a prospective study on 42 GHD subjects [22 men, mean age (sd): 48 \u00b1 10]: 10 acromegalics treated with recombinant human GH (group A), 12 acromegalics who refused treatment (group B), and 20 subjects operated for nonfunctioning pituitary adenoma on recombinant human GH (group C). Serum IGF-I levels, lipid profile, glucose levels (fasting and after an oral glucose tolerance test), glycosylated hemoglobin, insulin resistance (homeostasis model assessment insulin resistance index), anthropometric parameters (body mass index, waist circumference, body composition), and quality of life (Questions on Life Satisfaction-Hypopituitarism Z-scores) were evaluated at baseline and after 12 and 36 months.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results:<\/jats:title>\n                  <jats:p>At baseline, group B showed higher IGF sd score than group A and C, as well as better quality of life and higher post-oral glucose tolerance test glucose levels than group A. After 12-months, similarly in group A and C, the IGF-I sd score significantly increased, and body composition and lipid profile improved, without deterioration of glucose tolerance. Quality of life significantly improved too, and the baseline difference between group A and B disappeared. Results were confirmed after 36 months.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions:<\/jats:title>\n                  <jats:p>In GHD acromegalic patients, GH therapy improved body composition, lipid profile, and quality of life as in patients with GHD due to nonfunctioning pituitary adenoma, without negative effects on glucose metabolism. GH replacement therapy should be considered in these patients, as in patients with GHD from other causes.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1210\/jc.2012-2477","type":"journal-article","created":{"date-parts":[[2012,11,5]],"date-time":"2012-11-05T18:55:14Z","timestamp":1352141714000},"page":"3983-3988","source":"Crossref","is-referenced-by-count":23,"title":["GH Replacement Improves Quality of Life and Metabolic Parameters in Cured Acromegalic Patients with Growth Hormone Deficiency"],"prefix":"10.1210","volume":"97","author":[{"given":"Claudia","family":"Giavoli","sequence":"first","affiliation":[{"name":"Department of Clinical Sciences and Community Health (C.G., E.P., E.V., E.F., S.B., E.S., E.M., M.A., A.S., P.B.-P.), University of Milan,"},{"name":"Endocrinology and Diabetology Unit (C.G., E.P., E.V., E.F., S.B., E.S., E.M., A.S., P.B.-P.), Fondazione Istituto di Ricovero e Cura a Carattere Scientifico C\u00e0 Granda Ospedale Maggiore Policlinico, Milan, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eriselda","family":"Profka","sequence":"additional","affiliation":[{"name":"Department of Clinical Sciences and Community Health (C.G., E.P., E.V., E.F., S.B., E.S., E.M., M.A., A.S., P.B.-P.), University of Milan,"},{"name":"Endocrinology and Diabetology Unit (C.G., E.P., E.V., E.F., S.B., E.S., E.M., A.S., P.B.-P.), Fondazione Istituto di Ricovero e Cura a Carattere Scientifico C\u00e0 Granda Ospedale Maggiore Policlinico, Milan, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisa","family":"Verrua","sequence":"additional","affiliation":[{"name":"Department of Clinical Sciences and Community Health (C.G., E.P., E.V., E.F., S.B., E.S., E.M., M.A., A.S., P.B.-P.), University of Milan,"},{"name":"Endocrinology and Diabetology Unit (C.G., E.P., E.V., E.F., S.B., E.S., E.M., A.S., P.B.-P.), Fondazione Istituto di Ricovero e Cura a Carattere Scientifico C\u00e0 Granda Ospedale Maggiore Policlinico, Milan, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristina L.","family":"Ronchi","sequence":"additional","affiliation":[{"name":"University Hospital (C.L.R.), 97080 Wuerzburg, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emanuele","family":"Ferrante","sequence":"additional","affiliation":[{"name":"Department of Clinical Sciences and Community Health (C.G., E.P., E.V., E.F., S.B., E.S., E.M., M.A., A.S., P.B.-P.), University of Milan,"},{"name":"Endocrinology and Diabetology Unit (C.G., E.P., E.V., E.F., S.B., E.S., E.M., A.S., P.B.-P.), Fondazione Istituto di Ricovero e Cura a Carattere Scientifico C\u00e0 Granda Ospedale Maggiore Policlinico, Milan, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvia","family":"Bergamaschi","sequence":"additional","affiliation":[{"name":"Department of Clinical Sciences and Community Health (C.G., E.P., E.V., E.F., S.B., E.S., E.M., M.A., A.S., P.B.-P.), University of Milan,"},{"name":"Endocrinology and Diabetology Unit (C.G., E.P., E.V., E.F., S.B., E.S., E.M., A.S., P.B.-P.), Fondazione Istituto di Ricovero e Cura a Carattere Scientifico C\u00e0 Granda Ospedale Maggiore Policlinico, Milan, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisa","family":"Sala","sequence":"additional","affiliation":[{"name":"Department of Clinical Sciences and Community Health (C.G., E.P., E.V., E.F., S.B., E.S., E.M., M.A., A.S., P.B.-P.), University of Milan,"},{"name":"Endocrinology and Diabetology Unit (C.G., E.P., E.V., E.F., S.B., E.S., E.M., A.S., P.B.-P.), Fondazione Istituto di Ricovero e Cura a Carattere Scientifico C\u00e0 Granda Ospedale Maggiore Policlinico, Milan, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena","family":"Malchiodi","sequence":"additional","affiliation":[{"name":"Department of Clinical Sciences and Community Health (C.G., E.P., E.V., E.F., S.B., E.S., E.M., M.A., A.S., P.B.-P.), University of Milan,"},{"name":"Endocrinology and Diabetology Unit (C.G., E.P., E.V., E.F., S.B., E.S., E.M., A.S., P.B.-P.), Fondazione Istituto di Ricovero e Cura a Carattere Scientifico C\u00e0 Granda Ospedale Maggiore Policlinico, Milan, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea G.","family":"Lania","sequence":"additional","affiliation":[{"name":"BIOMETRA Department (A.G.L.), University of Milan and Endocrine Unit, Humanitas Cinical and Research Center, Rozzano, 20089 Milan, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maura","family":"Arosio","sequence":"additional","affiliation":[{"name":"Department of Clinical Sciences and Community Health (C.G., E.P., E.V., E.F., S.B., E.S., E.M., M.A., A.S., P.B.-P.), University of Milan,"},{"name":"Unit of Endocrine Diseases (M.A.), Ospedale S. Giuseppe Multimedica, 20123 Milan, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruno","family":"Ambrosi","sequence":"additional","affiliation":[{"name":"Department of Medical and Surgical Sciences (B.A.), University of Milan, Istituto di Ricovero e Cura a Carattere Scientifico Policlinico San Donato, 20097 San Donato Milanese, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Spada","sequence":"additional","affiliation":[{"name":"Department of Clinical Sciences and Community Health (C.G., E.P., E.V., E.F., S.B., E.S., E.M., M.A., A.S., P.B.-P.), University of Milan,"},{"name":"Endocrinology and Diabetology Unit (C.G., E.P., E.V., E.F., S.B., E.S., E.M., A.S., P.B.-P.), Fondazione Istituto di Ricovero e Cura a Carattere Scientifico C\u00e0 Granda Ospedale Maggiore Policlinico, Milan, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paolo","family":"Beck-Peccoz","sequence":"additional","affiliation":[{"name":"Department of Clinical Sciences and Community Health (C.G., E.P., E.V., E.F., S.B., E.S., E.M., M.A., A.S., P.B.-P.), University of Milan,"},{"name":"Endocrinology and Diabetology Unit (C.G., E.P., E.V., E.F., S.B., E.S., E.M., A.S., P.B.-P.), Fondazione Istituto di Ricovero e Cura a Carattere Scientifico C\u00e0 Granda Ospedale Maggiore Policlinico, Milan, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"80","reference":[{"key":"2020071617382685300_B1","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1111\/j.1365-2265.2011.04019.x","article-title":"The effects of long-term growth hormone and insulin-like growth factor-1 exposure on the development of cardiovascular, cerebrovascular and metabolic co-morbidities in treated patients with acromegaly.","volume":"75","author":"Jayasena","year":"2011","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2020071617382685300_B2","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1530\/EJE-12-0084","article-title":"Predictors of morbidity and mortality in acromegaly, an Italian survey.","volume":"167","author":"Arosio","year":"2012","journal-title":"Eur J Endocrinol"},{"key":"2020071617382685300_B3","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1530\/EJE-09-0222","article-title":"Prevalence of GH deficiency in cured acromegalic patients: impact of different previous treatments.","volume":"161","author":"Ronchi","year":"2009","journal-title":"Eur J Endocrinol"},{"key":"2020071617382685300_B4","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1210\/er.16.1.63","article-title":"Clinical aspects of growth hormone deficiency in adults.","volume":"16","author":"de Boer","year":"1995","journal-title":"Endocr Rev"},{"key":"2020071617382685300_B5","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1056\/NEJM198912283212605","article-title":"The effects of treatment with recombinant human growth hormone on body composition and metabolism in adult with growth hormone deficiency.","volume":"321","author":"Salomon","year":"1989","journal-title":"N Engl J Med"},{"key":"2020071617382685300_B6","doi-asserted-by":"crossref","first-page":"3913","DOI":"10.1210\/jcem.83.11.5223","article-title":"Optimizing growth hormone replacement therapy by dose titration in hypopituitary adults.","volume":"83","author":"Drake","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071617382685300_B7","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1210\/jc.2011-0179","article-title":"Evaluation and treatment of adult growth hormone deficiency: an Endocrine Society Clinical Practice guideline.","volume":"96","author":"Molitch","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071617382685300_B8","doi-asserted-by":"crossref","DOI":"10.1111\/j.1365-2265.2012.04361.x","article-title":"Effects of growth hormone deficiency on body composition and biomarkers of cardiovascular risk after definitive therapy for acromegaly","author":"Lin","year":"2012","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2020071617382685300_B9","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1530\/eje.0.1460067","article-title":"Growth hormone deficiency and replacement in hypopituitary patients previously treated for acromegaly or Cushing's disease.","volume":"146","author":"Feldt-Rasmussen","year":"2002","journal-title":"Eur J Endocrinol"},{"key":"2020071617382685300_B10","doi-asserted-by":"crossref","first-page":"2531","DOI":"10.1210\/jc.2007-2673","article-title":"Baseline characteristics and the effects of two years of growth hormone (GH) replacement therapy in adults with GH deficiency previously treated for acromegaly.","volume":"93","author":"Norrman","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071617382685300_B11","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1007\/s11102-009-0186-y","article-title":"Limited effects of growth hormone replacement in patients with GH deficiency during long-term cure of acromegaly.","volume":"12","author":"van der Klaauw","year":"2009","journal-title":"Pituitary"},{"key":"2020071617382685300_B12","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1210\/jc.2009-1611","article-title":"Growth hormone deficiency after treatment of acromegaly: a randomized, placebo-controlled study of growth hormone replacement.","volume":"95","author":"Miller","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071617382685300_B13","doi-asserted-by":"crossref","first-page":"209","DOI":"10.4158\/EP11134.OR","article-title":"Effect of growth hormone replacement therapy on the quality of life in women with growth hormone deficiency who have a history of acromegaly versus other disorders.","volume":"18","author":"Valassi","year":"2012","journal-title":"Endocr Pract"},{"key":"2020071617382685300_B14","doi-asserted-by":"crossref","first-page":"3141","DOI":"10.1210\/jc.2009-2670","article-title":"A consensus on criteria for cure of acromegaly.","volume":"95","author":"Giustina","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071617382685300_B15","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1530\/eje.1.01967","article-title":"The cut-off limits of the GH response to GH-releasing hormone-arginine test related to body mass index.","volume":"153","author":"Corneli","year":"2005","journal-title":"Eur J Endocrinol"},{"key":"2020071617382685300_B16","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1530\/eje.1.02163","article-title":"GH deficiency in patients irradiated for acromegaly: significance of GH stimulatory tests in relation to the 24 h GH secretion.","volume":"154","author":"van der Klaaw","year":"2006","journal-title":"Eur J Endocrinol"},{"key":"2020071617382685300_B17","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/S1096-6374(03)00124-2","article-title":"Evaluation of growth hormone stimulation tests in cured acromegalic patients.","volume":"13","author":"Concei\u00e7\u00e3o","year":"2003","journal-title":"Growth Horm IGF Res"},{"key":"2020071617382685300_B18","doi-asserted-by":"crossref","first-page":"5397","DOI":"10.1210\/jc.2004-1114","article-title":"Effect of recombinant human growth hormone (GH) replacement on the hypothalamic-pituitary-adrenal axis in adult GH-deficient patients.","volume":"89","author":"Giavoli","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071617382685300_B19","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.1210\/jcem.87.5.8479","article-title":"Recombinant human GH therapy and thyroid function in a large group of adult GH-deficient patient: when does L-T(4) therapy become mandatory?","volume":"87","author":"Porretti","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071617382685300_B20","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/BF00280883","article-title":"Homeostasis model assessment: insulin resistance and \u03b2-cell function from fasting plasma glucose and insulin concentrations in man.","volume":"28","author":"Matthews","year":"1985","journal-title":"Diabetologia"},{"key":"2020071617382685300_B21","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1093\/clinchem\/18.6.499","article-title":"Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge.","volume":"18","author":"Friedwald","year":"1972","journal-title":"Clin Chem"},{"key":"2020071617382685300_B22","doi-asserted-by":"crossref","first-page":"4158","DOI":"10.1210\/jc.2002-021792","article-title":"Decreased quality of life in adult patients with growth hormone deficiency compared with general populations using the new, validated, self-weighted questionnaire, questions on life satisfaction hypopituitarism module.","volume":"88","author":"Blum","year":"2003","journal-title":"J Clin Endocrinol Metab"}],"container-title":["The Journal of Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/97\/11\/3983\/10746586\/jcem3983.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/97\/11\/3983\/10746586\/jcem3983.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,17]],"date-time":"2020-07-17T03:33:55Z","timestamp":1594956835000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/97\/11\/3983\/2836478"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,11,1]]},"references-count":22,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2012,11,1]]}},"URL":"https:\/\/doi.org\/10.1210\/jc.2012-2477","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,11,1]]}}}